Sahajanand Medical Technologies is set to open its book-built IPO of ₹475.48 crores, fully a fresh issue with 1.38 crore shares on offer. 15 October, 2026 to 19 October, 2026 is the date for opening/closing of the subscription process. Shares will be allotted around 21 October, 2026, with the final listing expected to take place on 23 October, 2026, on both the NSE and BSE.
The company’s IPO price band is ₹327 to ₹344 per equity share, and the lot size is 43 equity shares. The minimum investment for retail investors is ₹14,792 based on the higher end of the price band. Motilal Oswal Investment Advisors Ltd. Is the book-running lead manager, and MUFG Intime India Pvt. Ltd is the registrar.
Sahajanand Medical Technologies IPO Allotment Status
| Company Name | Allotment Date | Listing Date | Registrar (Check Link) |
|---|---|---|---|
| Sahajanand Medical Technologies | Wed, Oct 21, 2026 | Fri, Oct 23, 2026 | https://in.mpms.mufg.com/Initial_Offer/public-issues.html |
Sahajanand Medical Technologies IPO Overview
| Details | Descriptions |
|---|---|
| IPO Date | 15 to 19 Oct, 2026 |
| Listing Date | Fri, Oct 23, 2026 |
| Face Value | ₹1 per share |
| Price Band | ₹327 to ₹344 |
| Lot Size | 43 Shares |
| Sale Type | OFS only |
| Total Issue Size | 1,38,22,116 shares (agg. up to ₹475 Cr) |
| Offer for Sale | 1,38,22,116 shares of ₹1 (agg. up to ₹475 Cr) |
| Issue Type | Bookbuilding IPO |
| Listing At | BSE, NSE |
| Share Holding Pre Issue | 10,16,46,778 shares |
| Share Holding Post Issue | 10,16,46,778 shares |
Sahajanand Medical Technologies IPO Schedule
| Details | Description |
|---|---|
| IPO Open Date | Thu, Oct 15, 2026 |
| IPO Close Date | Mon, Oct 19, 2026 |
| Tentative Allotment | Wed, Oct 21, 2026 |
| Initiation of Refunds | Thu, Oct 22, 2026 |
| Credit of Shares to Demat | Thu, Oct 22, 2026 |
| Tentative Listing Date | Fri, Oct 23, 2026 |
Sahajanand Medical Technologies Lot Size Details
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 43 | ₹14,792 |
| Retail (Max) | 13 | 559 | ₹1,92,296 |
| S-HNI (Min) | 14 | 602 | ₹2,07,088 |
| S-HNI (Max) | 67 | 2881 | ₹9,91,064 |
| B-HNI (Min) | 68 | 2924 | ₹10,05,856 |
Issue Reservation
| Investor Category | Shares |
|---|---|
| QIB | Not more than 50% of the Net Offer |
| NII | Not less than 15.00% of the Net Issue |
| Retail | Not less than 35.00% of the Net Issue |
Investor Category Reservations
| Category | Limit | Cut-off |
|---|---|---|
| RII | Up to ₹2 Lakhs | Yes |
| sNII | ₹2 Lakhs – ₹10 Lakhs | No |
| bNII | Above ₹10 Lakhs | No |
| Employee (EMP) | Up to ₹5 Lakhs | Yes |
| Employee + RII/NII | Up to ₹5Lakhs (EMP) + RII/NII limits | Yes (EMP/RII) |
Sahajanand Medical Technologies IPO GMP Trend
| GMP Date | IPO Price | GMP | Est. Listing Price | Est. Profit* |
|---|---|---|---|---|
| 14-Oct 10:37 | ₹344 | ₹42 (12.21%) ▲ | ₹386 | ₹1,806 |
| 13-Oct 11:00 | ₹344 | ₹41 (11.92%) ▲ | ₹385 | ₹1,763 |
| 12-Oct 10:37 | ₹344 | ₹35 (10.17%) ▼ | ₹379 | ₹1,505 |
| 11-Oct 21:37 | ₹344 | ₹40 (0.00%) ─ | ₹40 | ₹0 |
Overview of Sahajanand Medical Technologies
Founded in October 2001, SMT is a prominent medical technology company that designs, manufactures and sells cutting-edge cardiovascular devices worldwide. SMT mainly targets vascular and structural heart market segments, providing a full range of products, including coronary stent, coronary balloon, TAVI (transcatheter aortic valve implantation) device, occluders, renal stent and peripheral DCB. With the support of clinical research and innovative products, SMT has been known for the flagship brands namely Supraflex Cruz, Cocoon and Hydra in the industry.
Manufacturing, Global Reach, & Financial Performance
SMT has significant global operations through its manufacturing facilities and R&D centres located at India and Thailand. The company has 119 granted patents, 78 patent applications pending and five design registrations in India as of June 30, 2026.
SMT sells life-saving devices in 77 countries through a combination of direct and hybrid markets as well as through a network of distributors, with a compelling presence in India, Europe, and other international markets.
- Revenue Growth: Revenue from operations for FY2026 stood at ₹12,105.04 million – a consistent increase from FY2025’s ₹10,248.79 million and FY2024’s ₹9,016.04 million.
- Workforce: SMT is primarily supported by a full-time complement of 1,605 members, 31 strategic members and 707 contract members as at mid-2026.
Core Competitive Strengths
- Advanced Product Portfolio: High-precision medical devices operating in high-barrier, technology-driven healthcare sectors.
- Global Sales & Distribution: Extensive international footprint spanning direct and distributor-led sales networks.
- R&D & Innovation Focus: In-house research hubs continuously expanding an impressive global patent portfolio.
- Diversified Manufacturing: Modern, integrated production facilities certified to meet international regulatory standards.
- Strategic Growth & Leadership: Proven track record in strategic M&A activities, guided by an experienced management team and backed by marquee institutional investors.
Company Financials
Sahajanand Medical Technologies Financial Information (Restated Standalone)
| Period Ended | 30 Jun 2026 | 31 Mar 2026 | 31 Mar 2025 | 31 Mar 2024 |
|---|---|---|---|---|
| Assets | 1,309.00 | 1,276.43 | 1,094.90 | 970.58 |
| Total Income | 354.33 | 1,218.73 | 1,035.96 | 908.59 |
| Profit After Tax | 15.09 | 69.08 | 25.15 | -7.35 |
| EBITDA | 48.58 | 170.66 | 128.02 | 110.05 |
| NET Worth | 631.72 | 616.05 | 545.23 | 526.30 |
| Reserves and Surplus | 706.86 | 692.48 | 580.71 | 556.57 |
| Total Borrowing | 320.63 | 269.53 | 224.96 | 175.27 |
Key Performance Indicator (KPI)
The market cap. of Sahajanand Medical Technologies IPO is for Pre IPO ₹3,496.65 Cr., & for Post IPO ₹3,496.65 Crores.
KPI as of Mar 31, 2026
| KPI | Jun 30, 2026 | Mar 31, 2026 |
|---|---|---|
| ROE | 2.07% | 10.35% |
| ROCE | 3.16% | 11.57% |
| Debt/Equity | 0.33 | 0.27 |
| RoNW | 2.31% | 10.60% |
| PAT Margin | 4.29% | 5.71% |
| EBITDA Margin | 13.81% | 14.10% |
| NAV | 64.35 | 62.76 |
| Price to Book Value | – | 5.48 |
IPO Valuation & Shareholding Structure
| Pre IPO | Post IPO | |
|---|---|---|
| EPS Rs | 6.80 | 5.94 |
| P/E (x) | 50.59 | 57.91 |
| Company Promoters: | Bhargav Dhirajlal Kotadia, Dhirajlal Vallabhbhai Kotadia, Priyanka Dhirajlal Cohen and Shree Hari Trust. | |
| Promoter and Promoter Group | 40.82% | 36.2% |
| Public | 59.18% | 63.80% |
| Total | 100% | 100% |
Offer For Sale – Selling Shareholders
| Name | Category | No. of Shares Offered | Amount (₹ cr.) |
|---|---|---|---|
| Shree Hari Trust | Promoter | 27,00,000 | 92.88 |
| Dhirajkumar Savjibhai Vasoya | Promoter | 20,00,000 | 68.80 |
| Samara Capital Markets Holding Ltd. | Corporate | 64,79,063 | 222.88 |
| Kotak Pre-IPO Opportunities Fund | Corporate | 13,07,875 | 44.99 |
| NHPEA Sparkle Holding BV | Corporate | 13,35,178 | 45.93 |
| Total | 1,38,22,116 | 475.48 |
Sahajanand Medical Technologies IPO Objectives
The Sahajanand Medical Technologies Ltd. IPO is a 100% Offer for Sale (OFS), so the company will not receive any funding and the entire IPO proceeds will go to the selling shareholders.
Sahajanand Medical Technologies IPO Contact Details
- Sahajanand Medical Technologies Ltd.
- Sahajanand Estate, Wakharia Wadi,
- NR. Dabholi Char Rasta
- Nani Ved, Ved Road
- Surat, Gujarat, 395004
- 022 49564000
- investors.grievance@smt.in
- Website: https://www.smtpl.com/
Sahajanand Medical Technologies IPO Registrar
MUFG Intime India Pvt.Ltd.
| Details | Descriptions |
|---|---|
| Phone: | 022-49186000 |
| Email: | sahajanandmedical.ipo@in.mpms.mufg.com |
| Website: | https://in.mpms.mufg.com/Initial_Offer/public-issues.html |
Sahajanand Medical Technologies IPO FAQs
When Sahajanand Medical Technologies IPO become available?
The IPO will open on Thu, Oct 15, 2026.
What is the minimum lot size for the Sahajanand Medical Technologies IPO?
The minimum lot size is 43 shares.
When will the shares for the Sahajanand Medical Technologies IPO be allotted?
The allotment is expected to be finalized on Wed, Oct 21, 2026
What is the expected listing date for the Sahajanand Medical Technologies IPO?
The tentative listing date is Fri, Oct 23, 2026.
How can I apply for the Sahajanand Medical Technologies IPO?
You can apply online through your bank or a broker using either the UPI or ASBA payment methods.
Read also – HD Fire Protect IPO
